Painkiller shows surprising Germ-Fighting power in lab tests
NCT ID NCT07285759
Summary
This was a laboratory experiment, not a human trial. Researchers tested whether a common pain medication (levobupivacaine), when mixed in solutions used for pain pumps, could kill Staphylococcus aureus bacteria. They ran the solutions through simulated pain pumps for 24 hours and then counted how many bacteria survived to see if the drug had an antibacterial effect.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAPHYLOCOCCUS AUREUS BACTERIAL CONTAMINATION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.